Who is sponsoring NCT04177433?

NCT04177433 is sponsored by University of Alberta.

What drugs are being tested in NCT04177433?

Interventions in NCT04177433: Depo-Medrol Injectable Product, Saline.

What condition does NCT04177433 study?

NCT04177433 studies Osteoarthritis of the Carpometacarpal Joint, Thumb Osteoarthritis.

Is NCT04177433 still recruiting?

NCT04177433 is currently completed. Last updated 2 April 2026.

Last reviewed 2026-04-02 · How we verify

NCT04177433

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of Intra-articular Corticosteroid Injection to Treat Osteoarthritis of the Carpometacarpal Joint

Completed Phase 4 Last updated 2 April 2026

What this trial tests

Phase 4 trial testing Depo-Medrol Injectable Product in Osteoarthritis of the Carpometacarpal Joint in 61 participants. Completed in 31 December 2025.

Timeline

2 December 2020

Primary endpoint
29 September 2025

31 December 2025

Quick facts

Lead sponsor	University of Alberta
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	61
Start date	2 December 2020
Primary completion	29 September 2025
Estimated completion	31 December 2025
Sites	1 location across Canada

Drugs / interventions tested

Depo-Medrol Injectable Product — full drug profile →
Saline

Conditions studied

Osteoarthritis of the Carpometacarpal Joint — all drugs for Osteoarthritis of the Carpometacarpal Joint →
Thumb Osteoarthritis — all drugs for Thumb Osteoarthritis →

Sponsor

University of Alberta

Who can join

18 and older, any sex, with Osteoarthritis of the Carpometacarpal Joint or Thumb Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized clinical trial (RCT) will evaluate 6-month outcomes following intra-articular injections for arthritis of the thumb carpometacarpal (CMC) joint by comparing corticosteroid plus local anesthetic versus saline (placebo) plus local anesthetic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Alberta trials

Trials by the same sponsor.

NCT03240900 — Electrical Stimulation for Improving Postoperative Breast Sensation · NA · not yet recruiting
NCT04231760 — The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD · Phase 1, PHASE2 · not yet recruiting
NCT06649604 — Reducing Pain From Retinal Laser With Vibrational Stimulation · NA · not yet recruiting
NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT06920914 — Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04177433 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alberta
Last refreshed: 2 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04177433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing